# Vida Health

> Vida Health is a San Francisco-based digital health company that pairs an AI-powered, personalized app with human coaches, dietitians, therapists, and physicians to prevent, manage, and reverse chronic physical and mental conditions. Its virtual cardiometabolic clinic treats obesity, diabetes, hypertension, and the depression and anxiety that travel with them, and is sold to employers and health plans as a clinically validated, cost-managed alternative to fragmented point solutions, including responsible GLP-1 prescribing.

- **Founded:** 2014
- **Headquarters:** San Francisco, California, United States
- **Founders:** Stephanie Tilenius (Founder & former CEO (2014-2023))
- **Team size:** ~620 employees
- **Products:** Vida App / Virtual Cardiometabolic Clinic, GLP-1 / Anti-Obesity Medication Management, Behavioral & Mental Health Support, Vida Self-Pay (Powered by RxSaveCard)
- **Notable:** Raised $216.5M total across six rounds since founding in 2014., Published peer-reviewed clinical outcomes in JMIR Diabetes showing clinically significant A1c reductions within four months., Spanish-language diabetes program achieved an average 1.23-point A1c reduction from a 9.65 baseline in four months.

## Products & services

- **Vida App / Virtual Cardiometabolic Clinic** — AI-powered mobile app offering video sessions, messaging, and personalized digital content with coaches, dietitians, therapists, and physicians to manage obesity, diabetes, hypertension, and related behavioral health conditions.
- **GLP-1 / Anti-Obesity Medication Management** — Responsible, clinically supervised GLP-1 and anti-obesity medication prescribing wrapped in lifestyle and behavioral support, designed to control costs and start patients on the least intensive effective therapy.
- **Behavioral & Mental Health Support** — Integrated therapy and coaching for stress, depression, and anxiety that accompany chronic physical conditions, including cognitive behavioral therapy and multicultural, Spanish-language programs.
- **Vida Self-Pay (Powered by RxSaveCard)** — A cost-reduction offering launched in January 2026 helping employers and members access affordable GLP-1 and other medications combined with Vida's holistic care.

## Achievements

- Raised $216.5M total across six rounds since founding in 2014.
- Published peer-reviewed clinical outcomes in JMIR Diabetes showing clinically significant A1c reductions within four months.
- Spanish-language diabetes program achieved an average 1.23-point A1c reduction from a 9.65 baseline in four months.
- Became Quantum Health's exclusive GLP-1 solution, reaching 3M+ members.
- Featured as a Harvard Business School case study on transforming chronic disease treatment.
- Keeps GLP-1 starts to ~14% of managed members vs 40-50% in unmanaged settings, demonstrating cost discipline.

## Latest updates

- **2026-02** — Expanded cardiometabolic care to include MASH (metabolic dysfunction-associated steatohepatitis), targeting a fast-growing obesity-related cost driver.
- **2026-01** — Launched Vida Self-Pay (Powered by RxSaveCard) to reduce rising GLP-1 and prescription costs for employers.
- **2025** — Partnered with Amwell to launch 'Amwell Cardiometabolic Care Powered by Vida.'
- **2023-11** — Appointed Joe Murad CEO and closed $28.5M in financing led by Hercules Capital; founder Stephanie Tilenius stepped down after nine years.

## Links

- Website: https://www.vida.com
- LinkedIn: https://www.linkedin.com/company/vida-health
- Twitter/X: https://twitter.com/vida/
- Instagram: https://www.instagram.com/vidahealth/
- Facebook: https://facebook.com/joinvida/

---

Profile page: https://yespress.io/vida-health
Published by YesPress — https://yespress.io
Last updated: 2026-06-01